LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 125 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $138,000 | +13.1% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $122,000 | -8.3% | 22,000 | +10.0% | 0.00% | 0.0% |
| Q4 2018 | $133,000 | -37.6% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $213,000 | +10.9% | 20,000 | +25.0% | 0.00% | 0.0% |
| Q2 2018 | $192,000 | +47.7% | 16,000 | +5.3% | 0.00% | 0.0% |
| Q1 2018 | $130,000 | -9.7% | 15,200 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $144,000 | -19.6% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $179,000 | -25.4% | 14,600 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $240,000 | +14.8% | 14,600 | 0.0% | 0.00% | +100.0% |
| Q1 2017 | $209,000 | +3.5% | 14,600 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $202,000 | -23.5% | 14,600 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $264,000 | +14.3% | 14,600 | -9.3% | 0.00% | 0.0% |
| Q2 2016 | $231,000 | +20.3% | 16,100 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $192,000 | -10.3% | 16,100 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $214,000 | +39.9% | 16,100 | +12.7% | 0.00% | 0.0% |
| Q3 2015 | $153,000 | +33.0% | 14,285 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $115,000 | – | 14,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 71,178,364 | $280,443,000 | 7.61% |
| BVF INC/IL | 14,360,000 | $56,578,000 | 2.05% |
| Integral Health Asset Management, LLC | 200,000 | $788,000 | 0.22% |
| Eversept Partners, LP | 797,694 | $3,142,914 | 0.20% |
| NEA Management Company, LLC | 2,382,286 | $9,386,000 | 0.19% |
| PINNACLE ASSOCIATES LTD | 2,127,662 | $8,383,000 | 0.14% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $141,000 | 0.06% |
| Virtus ETF Advisers LLC | 41,584 | $164,000 | 0.06% |
| Pegasus Asset Management, Inc. | 10,000 | $39,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 31,562 | $124,000 | 0.02% |